Long-Term Changes in Submacular Choroidal Thickness after Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 14-Mo Follow-Up

Abstract

Dear Editor,

We appreciate the letter from Kai Xiong Cheong and Colin S. Tan regarding our study “Long-term changes in submacular choroidal thickness after treatment for neovascular age-related macular degeneration”.1 We thank colleagues Cheong and Tan for sharing their experience on this topic.2,3 They addressed several issues that are important in the studies of choroidal thickness (CT) measurement. We agree mostly with this comment; however, we need to explain some issues taking place methodologically in our study.